The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCVS Group Regulatory News (CVSG)

Share Price Information for CVS Group (CVSG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 975.00
Bid: 970.00
Ask: 975.00
Change: 20.00 (2.09%)
Spread: 5.00 (0.515%)
Open: 947.00
High: 982.00
Low: 946.00
Prev. Close: 955.00
CVSG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Board Appointments

29 Nov 2019 07:00

RNS Number : 0705V
CVS Group plc
29 November 2019
 

29 November 2019

 

CVS Group plc

 

("CVS" or the "Company")

 

Board Appointments

 

Further to the announcement on 6 November 2019, CVS Group plc, one of the UK's leading providers of integrated veterinary services, confirms that Ben Jacklin and Robin Alfonso have now been appointed Board Directors with immediate effect in their respective roles as Chief Operating Officer and Finance Director.

 

Richard Connell, CVS Group Chairman, said:

 

"On behalf of the Board, I am pleased to welcome both Ben and Robin to the CVS Board as Chief Operating Officer and Finance Director respectively. They bring complementary skills to the existing Board, alongside those of Richard Fairman who became CEO in November.

 

"Richard, Robin and Ben have already been working very well together for some time, providing strong continuity of leadership and maintaining good working relationships across our wider management executive, and this is reflected in the Group's performance. Yesterday's positive AGM trading update reflects the continuing efforts of all our dedicated colleagues to provide the highest levels of clinical care to our customers and their animals. The Board looks forward to working with them all to deliver further success for the business." 

 

As previously stated, given the appointment of an additional executive director, CVS is also conducting an initial evaluation with regard to appointing an additional independent non-executive director to maintain appropriate balance on its Board, in line with its adoption of the UK Corporate Governance Code. 

Enquiries:

 

CVS Group plc

+44 (0) 1379 644 288

Richard Connell, Non-executive Chairman

Richard Fairman, Chief Executive Officer

 

 

 

 

 

N+1 Singer (Nominated Adviser and Broker)

+44 (0) 20 7496 3000

Aubrey Powell / Rachel Hayes

 

 

 

 

Biographical information relating to both new Directors was included in the announcement of 6 November 2019, in relation to their proposed appointed and other directorate changes.

 

Additional disclosures required under the AIM Rules for Companies:

 

In relation to the appointment of Benjamin David Jacklin, aged 35:

 

Current directorships/partnerships

Past directorships/partnerships

Pet Emergency Treatment Services Limited

Pets Holding Limited

CVS (UK) Limited

n/a

 

In relation to the appointment of Robin Jay Alfonso, aged 40:

 

Current directorships/partnerships

Past directorships/partnerships

Pet Emergency Treatment Services Limited

Pets Holding Limited

CVS (UK) Limited

n/a

 

Following their appointment as Directors of the Company, Mr. Jacklin and Mr. Alfonso will assume additional directorships of other Group subsidiaries.

 

Save for the above, there are no further disclosures to be made in accordance with Rule 17 and Schedule 2 paragraph (g) of the AIM Rules for Companies.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAUWSKRKUAAUAA
Date   Source Headline
30th Dec 20227:00 amRNSExercise of Options and Total Voting Rights
20th Dec 20224:38 pmRNSExercise of Options and PDMR Dealing
30th Nov 20227:00 amRNSExercise of Options and Total Voting Rights
25th Nov 20224:22 pmRNSSAYE Option Scheme & PDMR Dealing
23rd Nov 20222:31 pmRNSResult of AGM
23rd Nov 20227:00 amRNSAGM Statement and Trading Update
8th Nov 20227:00 amRNSCapital Markets Day
31st Oct 20227:00 amRNSExercise of Options and Total Voting Rights
28th Oct 202210:22 amRNSAnnual Report, Notice of AGM & Dividend Timetable
12th Oct 202210:52 amRNSHolding(s) in Company
7th Oct 20227:00 amRNSDirector/PDMR Shareholding
30th Sep 20224:19 pmRNSLong Term Incentive Plan Awards and PDMR Dealing
30th Sep 20227:00 amRNSExercise of Options and Total Voting Rights
29th Sep 202210:34 amRNSHolding(s) in Company
28th Sep 20227:00 amRNSDirector/PDMR Shareholding
27th Sep 20224:19 pmRNSDirector/PDMR Shareholding
26th Sep 202211:56 amRNSDirector/PDMR Shareholding
23rd Sep 20227:00 amRNSDirector/PDMR Shareholding
23rd Sep 20227:00 amRNSDirector/PDMR Shareholding
22nd Sep 20227:00 amRNSFinal Results for the year ended 30 June 2022
31st Aug 20227:00 amRNSExercise of Options and Total Voting Rights
9th Aug 20229:30 amRNSHolding(s) in Company
29th Jul 20227:00 amRNSExercise of Options and Total Voting Rights
28th Jul 20227:00 amRNSTrading Update
13th Jul 20227:00 amRNSAppointment of Nominated Advisor and Joint Brokers
12th Jul 20227:00 amRNSBlock Listing Interim Review and TVR Update
1st Jul 20227:00 amRNSConclusion of CMA process, acquisition and trading
30th Jun 20227:00 amRNSExercise of Options and Total Voting Rights
13th Jun 20223:00 pmRNSPostponement to Capital Markets Day
8th Jun 20221:54 pmRNSHolding(s) in Company
31st May 20227:00 amRNSExercise of Options and Total Voting Rights
6th May 20227:00 amRNSAcquisition of Anton Vets
29th Apr 20227:00 amRNSExercise of Options and Total Voting Rights
31st Mar 20227:00 amRNSExercise of Options and Total Voting Rights
28th Mar 202210:47 amRNSHolding(s) in Company
24th Mar 20222:54 pmRNSDirector/PDMR Shareholding
24th Mar 202210:03 amRNSHolding(s) in Company
24th Mar 20227:00 amRNSInterim Results
21st Mar 20229:14 amRNSHolding(s) in Company
18th Mar 202210:17 amRNSHolding(s) in Company
3rd Mar 20228:38 amRNSHolding(s) in Company
28th Feb 20227:00 amRNSExercise of Options and Total Voting Rights
21st Feb 20225:37 pmRNSHolding(s) in Company
18th Feb 20227:15 amRNSCMA Update
3rd Feb 20229:43 amRNSHolding(s) in Company
31st Jan 20227:00 amRNSExercise of Options and Total Voting Rights
27th Jan 20227:00 amRNSTrading Update
13th Jan 20221:43 pmRNSBlock Listing Interim Review and TVR Update
4th Jan 20227:00 amRNSExercise of Options, PDMR Dealing and TVR
31st Dec 20217:00 amRNSExercise of Options and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.